Does laser ablation prostatectomy lead to oncological compromise?
| Autor: | Andrew Adamson, Alex J. King, Helen C. Oliver, Suzanne Biers |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
medicine.medical_specialty Urology medicine.medical_treatment Prostatic Hyperplasia urologic and male genital diseases Prostate cancer Prostate medicine Humans Transurethral resection of the prostate Aged Retrospective Studies Aged 80 and over Prostatectomy Incidental Findings Medical Audit business.industry Incidence (epidemiology) Transurethral Resection of Prostate Cancer Prostatic Neoplasms Middle Aged medicine.disease Prognosis Cancer registry medicine.anatomical_structure Treatment Outcome Histopathology Laser Therapy business |
| Zdroj: | BJU international. 103(4) |
| ISSN: | 1464-410X |
| Popis: | OBJECTIVE To assess the incidence and outcome of incidental prostate cancer detected at transurethral resection of the prostate (TURP), and to evaluate whether laser ablation prostatectomy would miss significant cancer by failing to provide tissue for histopathological analysis. PATIENTS AND METHODS Information on TURP-detected prostate cancer was gathered from 1996 to 2006, from The South-west Cancer Intelligence Service, hospital-operating and coding records, histopathology databases and The British Association of Urological Surgeons Cancer Registry. We recorded the total number of prostate cancers diagnosed per year, number of TURPs performed, Gleason scores and patients outcomes. RESULTS TURP-detected prostate cancer has declined since the relatively high rates (22%) recorded locally in 1996–97. Between 2001 and 2006, a mean (range) of 124 (111–135) prostate cancers were detected per year. Incidental cancers accounted for only 1.5–5.6% of all newly diagnosed prostate cancers per year. Incidental cancers had a mean (sem) Gleason score of 5.7 (0.3) compared to 8.0 (0.3) in known cancers (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text